Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination

被引:85
作者
Gupta, SK [1 ]
Bansal, P [1 ]
Bhardwaj, RK [1 ]
Velpandian, T [1 ]
机构
[1] All India Inst Med Sci, Dept Pharmacol, New Delhi 110029, India
关键词
nimesulide; piperine; writhing test; tail flick latency; LD50;
D O I
10.1006/phrs.1999.0640
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Piperine is an inhibitor of various hepatic and other enzymes involved in the biotransformation of drugs. Preliminary pharmacokinetic studies conducted by us suggested the increased bioavailability of nimesulide co-administered with piperine. The present study was, thus, conducted to evaluate the antinociceptive, anti-inflammatory and toxicity profile of a new nimesulide-piperine combination administered orally as compared with nimesulide alone. Antinociceptive efficacy was tested using an acetic acid writhing test and tail flick latency test (TFL). The ED50 value of a nimesulide-piperine combination in writhing test was calculated to be significantly lower (1.5 mg kg(-1)) as compared to (11.2 mg kg(-1)) of nimesulide alone. The antinociceptive effect was lesser in the tail flick latency test as compared to what was observed in the writhing test indicating the peripheral action of the Non-Steriodal Anti-Inflammatory Drug (NSAID). In carrageenan-induced inflammatory tests, the nimesulide-piperine combination was found to be dose-to-dose superior than nimesulide alone. Acute toxicity studies on mice revealed a reduction in lethal dose (LD50) of the combination (980 mg kg(-1)) as compared to nimesulide (1500 mg kg(-1)) alone. Results from the present study suggest a better therapeutic index for the nimesulide-piperine combination indicating that this combination would further reduce the frequency of adverse effects associated with nimesulide alone. (C) 2000 Academic Press.
引用
收藏
页码:657 / 662
页数:6
相关论文
共 26 条
[1]  
BERTI F, 1991, DRUG INVEST, V3, P39
[2]  
BEVILACQUA M, 1988, PAIN REPROD, V31, P265
[3]  
CORLI O, 1993, DRUGS, V46, P52
[4]  
D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74
[5]   DIFFERENCES IN THE EFFECTS OF PIPERINE AND PIPERONYL BUTOXIDE ON HEPATIC DRUG-METABOLIZING ENZYME-SYSTEM IN RATS [J].
DALVI, RR ;
DALVI, PS .
DRUG AND CHEMICAL TOXICOLOGY, 1991, 14 (1-2) :219-229
[6]   NIMESULIDE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY [J].
DAVIS, R ;
BROGDEN, RN .
DRUGS, 1994, 48 (03) :431-454
[7]  
Dreiser R L, 1993, Drugs, V46 Suppl 1, P191
[8]  
Ghosh M. N., 1984, FUNDAMENTAL EXPT PHA
[9]   INHIBITION OF CONSTITUTIVE AND INDUCIBLE CYCLOOXYGENASE ACTIVITY IN HUMAN PLATELETS AND MONONUCLEAR-CELLS BY NSAIDS AND COX-2 INHIBITORS [J].
GROSSMAN, CJ ;
WISEMAN, J ;
LUCAS, FS ;
TREVETHICK, MA ;
BIRCH, PJ .
INFLAMMATION RESEARCH, 1995, 44 (06) :253-257
[10]  
Gupta SK, 1998, PHYTOTHER RES, V12, P266, DOI 10.1002/(SICI)1099-1573(199806)12:4&lt